From: The triglyceride paradox in the mortality of coronary artery disease
Tertile 1 | Tertile 2 | Tertile 3 | |
---|---|---|---|
Total patients | |||
All-cause mortality, HR (95% CI) | |||
Unadjusted | 1.00 | 0.80 (0.59–1.09) | 0.53 (0.38–0.75) |
Adjusteda | 1.00 | 0.75 (0.53–1.05) | 0.49 (0.32–0.74) |
Cardiovascular mortality, HR (95% CI) | |||
Unadjusted | 1.00 | 0.69 (0.44–1.09) | 0.60 (0.37–0.95) |
Adjusteda | 1.00 | 0.57 (0.35–0.93) | 0.46 (0.27–0.81) |
ACS patients | |||
All-cause mortality, HR (95% CI) | |||
Unadjusted | 1.00 | 0.72 (0.51–1.04) | 0.53 (0.36–1.04) |
Adjusteda | 1.00 | 0.66 (0.45–0.97) | 0.53 (0.34–0.82) |
Cardiovascular mortality, HR (95% CI) | |||
Unadjusted | 1.00 | 0.68 (0.41–1.15) | 0.65 (0.38–1.10) |
Adjusteda | 1.00 | 0.53 (0.31–0.94) | 0.49 (0.27–0.89) |